Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             86 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Affinity assays for decrypting protein targets of unknown function Todd, Matthew J.
2005
35-36 3 p. 267-273
7 p.
artikel
2 Analytical ultracentrifugation: a powerful ‘new’ technology in drug discovery Laue, Tom
2004
35-36 3 p. 309-315
7 p.
artikel
3 Animal models of Alzheimer's disease and drug development Laurijssens, Bart
2013
35-36 3 p. e319-e327
nvt p.
artikel
4 Applying chemical tools to the discovery of novel regenerative medicine Wu, Tom Y.H.
2006
35-36 3 p. 255-260
6 p.
artikel
5 Automation of decision making in drug design Leahy, David E.
2013
35-36 3 p. e437-e441
nvt p.
artikel
6 Bridging the gap in the fight against tuberculosis Davies, G.R.
2013
35-36 3 p. e359-e364
nvt p.
artikel
7 Combination of ligand- and structure-based methods in virtual screening Drwal, Malgorzata N.
2013
35-36 3 p. e395-e401
nvt p.
artikel
8 Combined quantum and molecular mechanics (QM/MM) Friesner, Richard A.
2004
35-36 3 p. 253-260
8 p.
artikel
9 Competitive intelligence and patent analysis in drug discovery Grandjean, Nicolas
2005
35-36 3 p. 211-215
5 p.
artikel
10 Contents 2004
35-36 3 p. i-
1 p.
artikel
11 Contents 2013
35-36 3 p. i-ii
nvt p.
artikel
12 Data-driven computer aided synthesis design Ravitz, Orr
2013
35-36 3 p. e443-e449
nvt p.
artikel
13 De novo computer-aided design of novel antiviral agents Massarotti, Alberto
2012
35-36 3 p. e213-e218
nvt p.
artikel
14 Determination of absolute configuration via vibrational circular dichroism Kuppens, Tom
2004
35-36 3 p. 269-275
7 p.
artikel
15 Difference gel electrophoresis DIGE Lilley, Kathryn S
2006
35-36 3 p. 347-353
7 p.
artikel
16 Drug-like properties: guiding principles for design – or chemical prejudice? Leeson, Paul D.
2004
35-36 3 p. 189-195
7 p.
artikel
17 Editorial 2005
35-36 3 p. 193-195
3 p.
artikel
18 Editorial Herdewijn, Piet
2012
35-36 3 p. e175-e176
nvt p.
artikel
19 Essential enrichment strategies in phosphoproteomics Pinkse, Martijn W.H.
2006
35-36 3 p. 331-337
7 p.
artikel
20 Establishing in vitro to clinical correlations in the evaluation of cardiovascular safety pharmacology Chain, A.S.Y.
2013
35-36 3 p. e373-e383
nvt p.
artikel
21 Evaluation of symptomatic drug effects in Alzheimer's disease: strategies for prediction of efficacy in humans Deguil, J.
2013
35-36 3 p. e329-e342
nvt p.
artikel
22 Expanding the frontiers in proteomics Gavin, Anne-Claude
2006
35-36 3 p. 315-316
2 p.
artikel
23 Exploiting new approaches for natural product drug discovery in the biotechnology industry Gullo, Vincent P.
2005
35-36 3 p. 281-286
6 p.
artikel
24 Fast similarity searching and screening hit analysis Baringhaus, Karl-Heinz
2004
35-36 3 p. 197-202
6 p.
artikel
25 Fragment library design: efficiently hunting drugs in chemical space Boyd, Susan M.
2010
35-36 3 p. e173-e180
nvt p.
artikel
26 Fragments: past, present and future Whittaker, Mark
2010
35-36 3 p. e163-e171
nvt p.
artikel
27 Fueling HIV-1 integrase drug design with structural insights Demeulemeester, Jonas
2012
35-36 3 p. e205-e212
nvt p.
artikel
28 High throughput, nanoliter quantitative PCR Brenan, Colin
2005
35-36 3 p. 247-253
7 p.
artikel
29 Human aspects of the management of drug discovery knowledge Davenport, Thomas H.
2005
35-36 3 p. 205-209
5 p.
artikel
30 Humanised models of infection in the evaluation of anti-malarial drugs Angulo-Barturen, Iñigo
2013
35-36 3 p. e351-e357
nvt p.
artikel
31 Induced fit docking, and the use of QM/MM methods in docking Xu, Mengang
2013
35-36 3 p. e411-e418
nvt p.
artikel
32 Informatics, docking and data investigation Green, Darren V.S.
2013
35-36 3 p. e385-e386
nvt p.
artikel
33 Information extraction technologies for the life science industry Fluck, Juliane
2005
35-36 3 p. 217-224
8 p.
artikel
34 In silico antitarget screening Recanatini, Maurizio
2004
35-36 3 p. 209-215
7 p.
artikel
35 In silico docking and scoring of fragments Chen, Yu
2010
35-36 3 p. e149-e156
nvt p.
artikel
36 In silico virtual screening approaches for anti-viral drug discovery Murgueitio, Manuela S.
2012
35-36 3 p. e219-e225
nvt p.
artikel
37 In vitro combinatorial chemistry to create drug candidates Weber, Lutz
2004
35-36 3 p. 261-267
7 p.
artikel
38 Isothermal titration calorimetry: controlling binding forces in lead optimization Freire, Ernesto
2004
35-36 3 p. 295-299
5 p.
artikel
39 Large-scale SAR analysis Bajorath, Jürgen
2013
35-36 3 p. e419-e426
nvt p.
artikel
40 Lead identification in post-genomics: computers as a complementary alternative Klebe, Gerhard
2004
35-36 3 p. 225-230
6 p.
artikel
41 Ligand efficiency as a guide in fragment hit selection and optimization Schultes, Sabine
2010
35-36 3 p. e157-e162
nvt p.
artikel
42 Locked nucleic acid (LNA): High affinity targeting of RNA for diagnostics and therapeutics Kauppinen, Sakari
2005
35-36 3 p. 287-290
4 p.
artikel
43 Managing genomic and proteomic knowledge Lutz, Michael W.
2005
35-36 3 p. 197-204
8 p.
artikel
44 Medicinal chemistry Zhang, Li-he
2006
35-36 3 p. 239-240
2 p.
artikel
45 Modeling of human tumor xenografts and dose rationale in oncology Simeoni, Monica
2013
35-36 3 p. e365-e372
nvt p.
artikel
46 Multi-objective optimization methods in drug design Nicolaou, Christos A.
2013
35-36 3 p. e427-e435
nvt p.
artikel
47 New approaches for NMR screening in drug discovery Fernández, César
2004
35-36 3 p. 277-283
7 p.
artikel
48 New concepts and approaches for drug discovery based on traditional Chinese medicine Xu, Xiaojie
2006
35-36 3 p. 247-253
7 p.
artikel
49 New technologies in computer-aided drug design: Toward target identification and new chemical entity discovery Tang, Yun
2006
35-36 3 p. 307-313
7 p.
artikel
50 New trends in carbohydrate-based vaccines Roy, René
2004
35-36 3 p. 327-336
10 p.
artikel
51 Next generation sequencing technologies Jarvie, Thomas
2005
35-36 3 p. 255-260
6 p.
artikel
52 Ontologies in drug discovery Gardner, Stephen P.
2005
35-36 3 p. 235-240
6 p.
artikel
53 Optimization algorithms and natural computing in drug discovery Solmajer, Tom
2004
35-36 3 p. 247-252
6 p.
artikel
54 Pharmacophore definition and 3D searches Langer, T.
2004
35-36 3 p. 203-207
5 p.
artikel
55 Phospho-specific flow cytometry in drug discovery Clutter, Matthew R.
2005
35-36 3 p. 295-302
8 p.
artikel
56 Practical considerations for developing nucleoside reverse transcriptase inhibitors Hurwitz, Selwyn J.
2012
35-36 3 p. e183-e193
nvt p.
artikel
57 Profiling molecular interactions using label-free acoustic screening Cooper, Matthew A.
2005
35-36 3 p. 241-245
5 p.
artikel
58 Profiling the kinome for drug discovery Yan, S. Frank
2006
35-36 3 p. 269-276
8 p.
artikel
59 Progress in combinatorial biosynthesis for drug discovery Van Lanen, Steven G.
2006
35-36 3 p. 285-292
8 p.
artikel
60 Protein co-membership and biochemical affinity purifications Gavin, Anne-Claude
2006
35-36 3 p. 325-330
6 p.
artikel
61 Proteome-scale docking: myth and reality Rognan, Didier
2013
35-36 3 p. e403-e409
nvt p.
artikel
62 Proteomic analysis of GPI-anchored membrane proteins Jung, Hye Ryung
2006
35-36 3 p. 339-346
8 p.
artikel
63 Recent advances in microarrays Dill, Kilian
2005
35-36 3 p. 261-266
6 p.
artikel
64 Recent development of RNAi in drug target discovery and validation Liu, Guohong
2006
35-36 3 p. 293-300
8 p.
artikel
65 Scaffold hopping Böhm, Hans-Joachim
2004
35-36 3 p. 217-224
8 p.
artikel
66 Scoring functions for protein–ligand interactions: a critical perspective Schulz-Gasch, Tanja
2004
35-36 3 p. 231-239
9 p.
artikel
67 Serendipity and VZV drug discovery Derudas, Marco
2012
35-36 3 p. e177-e181
nvt p.
artikel
68 Single molecule technologies Rooke, Jenny E.
2005
35-36 3 p. 275-280
6 p.
artikel
69 Slow-MAS NMR: A new technology for in vivo metabolomic studies Wind, Robert A.
2005
35-36 3 p. 291-294
4 p.
artikel
70 Structural biology of the hepatitis C virus proteins Weiser, Briana M.
2012
35-36 3 p. e195-e204
nvt p.
artikel
71 Structure-based drug design: NMR-based approach for ligand–protein interactions Zhang, Xu
2006
35-36 3 p. 241-245
5 p.
artikel
72 Surface Plasmon Resonance biosensor analysis as a useful tool in FBDD Retra, Kim
2010
35-36 3 p. e181-e187
nvt p.
artikel
73 Targeting transcription factors in cancer: Challenges and evolving strategies Redell, Michele S.
2006
35-36 3 p. 261-267
7 p.
artikel
74 Techniques used for the discovery of therapeutic compounds: The case of SARS Chen, Shuai
2006
35-36 3 p. 277-283
7 p.
artikel
75 Technologies: preclinical imaging for drug development Matthews, Paul M.
2013
35-36 3 p. e343-e350
nvt p.
artikel
76 The heat is on: thermodynamic analysis in fragment-based drug discovery Edink, Ewald
2010
35-36 3 p. e189-e201
nvt p.
artikel
77 The HTS dogma is shattered, and now there are fragments everywhere de Esch, Iwan J.P.
2010
35-36 3 p. e147-e148
nvt p.
artikel
78 The potential of metabonomics in drug safety and toxicology Griffin, Julian L.
2004
35-36 3 p. 285-293
9 p.
artikel
79 The Semantic Web and Knowledge Grids Goble, Carole
2005
35-36 3 p. 225-233
9 p.
artikel
80 The synthesis of well-defined heparin and heparan sulfate fragments Codée, Jeroen D.C.
2004
35-36 3 p. 317-326
10 p.
artikel
81 Translational pharmacology: from animal to man and back Della Pasqua, Oscar
2013
35-36 3 p. e315-e317
nvt p.
artikel
82 Two-hybrid and its recent adaptations Lievens, Sam
2006
35-36 3 p. 317-324
8 p.
artikel
83 Use of high-throughput LC–MS/MS proteomics technologies in drug discovery Shen, Zhouxin
2006
35-36 3 p. 301-306
6 p.
artikel
84 Using 3D protein structures to derive 3D-QSARs Wade, Rebecca C.
2004
35-36 3 p. 241-246
6 p.
artikel
85 Very large virtual compound spaces: construction, storage and utility in drug discovery Peng, Zhengwei
2013
35-36 3 p. e387-e394
nvt p.
artikel
86 Why you should be using more SPR biosensor technology Rich, Rebecca L.
2004
35-36 3 p. 301-308
8 p.
artikel
                             86 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland